Literature DB >> 30707368

Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS).

Sowmyanarayanan Thuppal1, Stephen Markwell2, Traves Crabtree2, Stephen Hazelrigg3.   

Abstract

PURPOSE: Lung volume reduction surgery (LVRS) has been shown to improve lung function, but also improve the overall quality of life (QOL). The aim of this study is to compare two QOL questionnaires-EuroQol Questionnaire (EQ-5D-3L) and 36-item Short Form Health Survey (SF-36) in patients post-LVRS.
METHODS: All patients undergoing LVRS for severe chronic obstructive pulmonary disease (COPD) at a single center of excellence were analyzed (n = 94). Baseline demographic and clinical outcomes were characterized. Both EQ-5D-3L and SF-36 questionnaires were administered to all patients at baseline (n = 94) and at the end of 1 year (n = 89) post-surgery. SF-36 was converted to Short Form six-dimensions (SF-6D) using standard algorithm. Correlation, discrimination, responsiveness and differences across the two questionnaires were examined.
RESULTS: The mean age of patients enrolled in the cohort was 66 years. There was significant increase in forced expiratory volume (FEV1, 43%), forced vital capacity (FVC 46%), diffusion capacity (DLCO 15%), 6 min walk distance test (6MWD 21%) and a significant decrease in residual volume (RV 23%) at the end of 1-year follow-up. The overall mean utility index significantly improved for both SF-6D and EQ-5D-3L questionnaires at the end of follow-up (p = 0.0001). However, the magnitude of percentage increase was higher with EQ-5D-3L compared to SF-6D (32% vs. 13%). Stronger correlations confirmed convergent validity at the end of 1-year follow-up between similar domains. Both questionnaires failed to discriminate between different levels of disease severity post-LVRS in patients with severe COPD.
CONCLUSIONS: Both questionnaires responded similarly in patients with COPD post-LVRS. Combining results from QOL questionnaire(s) along with symptoms of disease and history of exacerbation may be a possible solution for identifying disease severity in old and sick patients unwilling/unable to come to hospital for a pulmonary function test post-LVRS.

Entities:  

Keywords:  EQ-5D-3L; LVRS; QOL; SF6D

Mesh:

Year:  2019        PMID: 30707368     DOI: 10.1007/s11136-019-02123-x

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  27 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

Review 2.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

Review 3.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

4.  Comparison of EQ-5D and SF-6D utilities in mental health patients.

Authors:  L M Lamers; C A M Bouwmans; A van Straten; M C H Donker; L Hakkaart
Journal:  Health Econ       Date:  2006-11       Impact factor: 3.046

5.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

6.  Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease.

Authors:  R S Goldstein; T R J Todd; G Guyatt; S Keshavjee; T E Dolmage; S van Rooy; B Krip; F Maltais; P LeBlanc; S Pakhale; T K Waddell
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

7.  EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients.

Authors:  Thomas Ringbaek; Eva Brøndum; Gerd Martinez; Peter Lange
Journal:  Respir Med       Date:  2008-08-09       Impact factor: 3.415

8.  A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.

Authors:  Paul McCrone; Anita Patel; Martin Knapp; Aart Schene; Maarten Koeter; Francesco Amaddeo; Mirella Ruggeri; Anne Giessler; Bernd Puschner; Graham Thornicroft
Journal:  J Ment Health Policy Econ       Date:  2009-03

9.  A comparison of the EQ-5D and SF-6D across seven patient groups.

Authors:  John Brazier; Jennifer Roberts; Aki Tsuchiya; Jan Busschbach
Journal:  Health Econ       Date:  2004-09       Impact factor: 3.046

10.  Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease.

Authors:  Henk F van Stel; Erik Buskens
Journal:  Health Qual Life Outcomes       Date:  2006-03-25       Impact factor: 3.186

View more
  3 in total

1.  Translation, Pilot Psychometric Validation, and Comparative Performance of the Arabic Version of the Anti-Clot Treatment Scale (ACTS).

Authors:  Sireen Abdul Rahim Shilbayeh; Sahar Abd El Rahman Ismail
Journal:  J Pharm Bioallied Sci       Date:  2020-12-16

2.  Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey.

Authors:  Shitong Xie; Dingyao Wang; Jing Wu; Chunyu Liu; Wenchen Jiang
Journal:  Health Qual Life Outcomes       Date:  2022-06-16       Impact factor: 3.077

3.  Clinical Observation of General Anesthesia Combined with Spinal Anesthesia in Elderly Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Jie Chen; Jing Wang; Xiaohui Duan; Fumin Ping; Aiming Zhang
Journal:  Biomed Res Int       Date:  2022-08-21       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.